Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Cancer Chemother Pharmacol ; 54(6): 546-52, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15316749

ABSTRACT

PURPOSE: Epirubicin and docetaxel are two of the most active drugs against breast carcinoma. As the achievement of a pathological complete response (pCR) is important for survival of patients with locally advanced disease, we used both drugs as neoadjuvant chemotherapy. PATIENTS AND METHODS: Women with locally advanced or inflammatory breast cancer received epirubicin 120 mg/m2 followed by docetaxel 75 mg/m2, both on day 1, every 21 days for four cycles. Lenograstim was administered for 10 days in all cycles. RESULTS: Of 51 patients included, 50 received a total of 188 cycles, with a median of 4 per patient. The median age was 47 years, tumour stage was IIIA in 14 patients and IIIB in 36. Oestrogen receptors were positive in 65% of tumours. There were 10 clinical complete responses (20%) and 29 partial responses (58%). Surgery consisted of mastectomy in 40 patients and tumorectomy in 6. After surgery, 9 pCR were recorded (18%). One patient progressed and died soon after the end of chemotherapy. After a median follow-up of 22 months, the median disease-free survival was 33.7 months. Grade 3/4 neutropenia was observed in 32% of patients, anaemia in 6%, and thrombocytopenia in 4%. Five patients had febrile neutropenia. There were no toxic deaths or grade 4 nonhaematological toxicities. CONCLUSIONS: Docetaxel plus high-dose epirubicin showed promising activity in patients with locally advanced and inflammatory breast cancer, at the cost of moderate toxicity.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Epirubicin/administration & dosage , Taxoids/administration & dosage , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Chemotherapy, Adjuvant , Disease-Free Survival , Docetaxel , Drug Administration Schedule , Epirubicin/adverse effects , Female , Humans , Middle Aged , Neoadjuvant Therapy , Taxoids/adverse effects , Treatment Outcome
2.
Eur J Cancer ; 33(8): 1256-61, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9301452

ABSTRACT

A case-control study on women was carried out in Barcelona, Spain, to investigate the relationship of lung cancer with the intake of vegetables, fruits and some foods of animal origin. The study included 103 cases and 206 controls matched by age and residence. Diet intake was assessed by means of a food frequency questionnaire. A reduction in risk, adjusted for smoking habit, was found for the intake of yellow/orange vegetables (mainly carrots) and tomatoes. The odds ratio (OR) and 95% confidence interval (CI) for the highest versus lowest tertile of intake were 0.37 (0.19-0.74) for yellow/orange vegetables and 0.45 (0.22-0.91) for tomatoes; both had a significant inverse trend. A tendency to a reduction in risk of lung cancer with increased intake was observed for all vegetables, leafy green vegetables, dark green vegetables and cruciferous, but these associations did not reach statistical significance. No association with lung cancer was found for the intake of fruits or foods of animal origin rich in retinol. Similar patterns were observed for women who never smoked and when the analysis was restricted to adenocarcinoma.


Subject(s)
Fruit , Lung Neoplasms/prevention & control , Vegetables , Adenocarcinoma/etiology , Adenocarcinoma/prevention & control , Adult , Aged , Aged, 80 and over , Case-Control Studies , Diet , Female , Humans , Lung Neoplasms/etiology , Middle Aged , Risk Factors , Smoking/adverse effects
4.
Rev Esp Cardiol ; 43(6): 408-9, 1990.
Article in Spanish | MEDLINE | ID: mdl-2236787

ABSTRACT

Syncope is a rare presentation of glossopharyngeal neuralgia (GN). A patient with squamous cell cancer of the pharynx had GN and syncope due to asystolic pauses and extreme hypotension. The bradyarrhythmias were atropine-sensible, but both this treatment and pacing failed to prevent recurrence of syncopal hypotensive crises, blood pressure continuing to fall during GN attacks. These data suggest that during a neuralgic attack the stimulation excites vagi, causing asystole, and simultaneously abolishes sympathetic tone. Carbamazepine was effective in controlling the symptoms of the patient.


Subject(s)
Glossopharyngeal Nerve/physiopathology , Hemodynamics/physiology , Neuralgia/etiology , Syncope/etiology , Carbamazepine/therapeutic use , Carcinoma, Squamous Cell/complications , Humans , Hypotension/complications , Male , Middle Aged , Neuralgia/physiopathology , Pharyngeal Neoplasms/complications , Syncope/drug therapy , Syncope/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...